Market Closed -
Australian S.E.
10:06:39 16/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.009
AUD
|
-10.00%
|
|
0.00%
|
+12.50%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
12.67
|
4.632
|
2.503
|
5.436
|
46.44
|
6.589
|
Enterprise Value (EV)
1 |
10.72
|
4.334
|
2.397
|
4.325
|
38.19
|
2.725
|
P/E ratio
|
-7.39
x
|
-0.88
x
|
-1.34
x
|
-6.6
x
|
-36.9
x
|
-6.15
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
269
x
|
372
x
|
52.5
x
|
-
|
-
|
-
|
EV / Revenue
|
227
x
|
348
x
|
50.2
x
|
-
|
-
|
-
|
EV / EBITDA
|
-6.55
x
|
-2.86
x
|
-2.57
x
|
-4.01
x
|
-35.5
x
|
-2.57
x
|
EV / FCF
|
-13
x
|
14
x
|
-2.13
x
|
-3.3
x
|
-15.9
x
|
-0.64
x
|
FCF Yield
|
-7.7%
|
7.17%
|
-46.9%
|
-30.3%
|
-6.28%
|
-157%
|
Price to Book
|
2.12
x
|
4.95
x
|
2.19
x
|
1.83
x
|
3.78
x
|
0.58
x
|
Nbr of stocks (in thousands)
|
90,499
|
90,822
|
1,47,267
|
2,71,791
|
5,04,766
|
5,06,822
|
Reference price
2 |
0.1400
|
0.0510
|
0.0170
|
0.0200
|
0.0920
|
0.0130
|
Announcement Date
|
27/09/18
|
24/09/19
|
28/09/20
|
29/09/21
|
29/09/22
|
27/09/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.0472
|
0.0125
|
0.0477
|
-
|
-
|
-
|
EBITDA
1 |
-1.638
|
-1.516
|
-0.9329
|
-1.077
|
-1.076
|
-1.061
|
EBIT
1 |
-1.715
|
-5.292
|
-1.687
|
-1.08
|
-1.082
|
-1.298
|
Operating Margin
|
-3,635.29%
|
-42,487.61%
|
-3,534.95%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-1.707
|
-5.273
|
-1.653
|
-0.7339
|
-0.9536
|
-1.069
|
Net income
1 |
-1.707
|
-5.272
|
-1.653
|
-0.7548
|
-0.9535
|
-1.069
|
Net margin
|
-3,619.04%
|
-42,330.73%
|
-3,464.04%
|
-
|
-
|
-
|
EPS
2 |
-0.0190
|
-0.0581
|
-0.0127
|
-0.003031
|
-0.002491
|
-0.002115
|
Free Cash Flow
1 |
-0.8251
|
0.3105
|
-1.124
|
-1.309
|
-2.399
|
-4.287
|
FCF margin
|
-1,749.32%
|
2,493.35%
|
-2,354.96%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/09/18
|
24/09/19
|
28/09/20
|
29/09/21
|
29/09/22
|
27/09/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1.95
|
0.3
|
0.11
|
1.11
|
8.25
|
3.86
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-0.83
|
0.31
|
-1.12
|
-1.31
|
-2.4
|
-4.29
|
ROE (net income / shareholders' equity)
|
-25.6%
|
-153%
|
-159%
|
-35.7%
|
-12.5%
|
-9.07%
|
ROA (Net income/ Total Assets)
|
-15.7%
|
-92.1%
|
-91%
|
-31%
|
-8.59%
|
-6.7%
|
Assets
1 |
10.87
|
5.725
|
1.816
|
2.431
|
11.1
|
15.97
|
Book Value Per Share
2 |
0.0700
|
0.0100
|
0.0100
|
0.0100
|
0.0200
|
0.0200
|
Cash Flow per Share
2 |
0.0200
|
0
|
0
|
0
|
0.0200
|
0.0100
|
Capex
1 |
0.8
|
0.31
|
0.46
|
0.95
|
1.98
|
3.78
|
Capex / Sales
|
1,703.24%
|
2,490.16%
|
964.43%
|
-
|
-
|
-
|
Announcement Date
|
27/09/18
|
24/09/19
|
28/09/20
|
29/09/21
|
29/09/22
|
27/09/23
|
|
1st Jan change
|
Capi.
|
---|
| +12.50% | 3.47M | | +17.02% | 66.52B | | +2.81% | 50.34B | | +17.88% | 42.01B | | +20.88% | 26.68B | | +11.82% | 19.97B | | +1.05% | 17.32B | | -23.54% | 15.7B | | +0.91% | 15.53B | | -11.00% | 14.99B |
Other Specialty Chemicals
|